ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $689,753 | -26.6% | 25,670 | -2.7% | 0.00% | -33.3% |
| Q2 2023 | $940,354 | +35.3% | 26,370 | -3.7% | 0.01% | +20.0% |
| Q1 2023 | $695,198 | -36.4% | 27,370 | +1.5% | 0.01% | -37.5% |
| Q4 2022 | $1,093,903 | +24.2% | 26,970 | +1.1% | 0.01% | +33.3% |
| Q3 2022 | $881,000 | -6.9% | 26,670 | -0.7% | 0.01% | 0.0% |
| Q2 2022 | $946,000 | -23.2% | 26,870 | +0.4% | 0.01% | -14.3% |
| Q1 2022 | $1,231,000 | -29.7% | 26,770 | +1.3% | 0.01% | -22.2% |
| Q4 2021 | $1,752,000 | +7.4% | 26,428 | +1.1% | 0.01% | 0.0% |
| Q3 2021 | $1,631,000 | -24.9% | 26,128 | -0.4% | 0.01% | -30.8% |
| Q2 2021 | $2,172,000 | -14.8% | 26,228 | -31.7% | 0.01% | -18.8% |
| Q1 2021 | $2,548,000 | -11.3% | 38,428 | +2.7% | 0.02% | -20.0% |
| Q4 2020 | $2,872,000 | +79.2% | 37,428 | +0.5% | 0.02% | +53.8% |
| Q3 2020 | $1,603,000 | +0.3% | 37,228 | +0.5% | 0.01% | -7.1% |
| Q2 2020 | $1,599,000 | +99.9% | 37,028 | +33.2% | 0.01% | +55.6% |
| Q1 2020 | $800,000 | -57.2% | 27,800 | -5.8% | 0.01% | -40.0% |
| Q4 2019 | $1,871,000 | – | 29,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |